Financial strength through innovation: The role of medical technology in healthcare efficiency

The new Prognos study commissioned by the Federation of German Industries (BDI) presents impressive figures: Innovations in the area of medical devices can save up to 9 billion euros annually in the German healthcare sector — through outpatient care, AI-based diagnostics, robot-assisted systems and intelligent materials such as 3D printing.

That is more than just cost efficiency. It is a signal to health policy: Innovation is not a luxury, but a necessity. The question is not whether we can afford innovations in medical devices — but whether we can afford to block them. The highest savings potential lies in outpatient care, where almost 3 million cases could generate savings of over 6 billion euros.

Where is the challenge?

While the economic potential is clear, the complexity of regulation is growing with strict requirements for transparency, safety, and clinical evidence. High-risk medical devices require robust data quality, documented human monitoring, and continuous performance monitoring.

This is not an obstacle, but the basis for trust.

Manufacturers who see these requirements not as hurdles but as quality features will establish themselves on the market. They will win over patients, doctors and payers because their products are not only innovative, but also evidence-based and trustworthy.

At MEDIACC, we support manufacturers in exactly this: from study planning to generating clinical evidence to conformity assessment in accordance with the Medical Device Regulation (MDR), the In Vitro Diagnostics Regulation (IVDR) and the Artificial Intelligence Regulation (AI Regulation). Because solid regulation and innovation go hand in hand.

The message is clear: The future of healthcare lies in the intelligent combination of regulatory excellence and economic efficiency.

How do you navigate your path to regulatory compliance with innovative medical devices?